The differences observed in the sensitivity of these brain tumor cell lines to exogenous SOX2 (introduced by lentiviral transduction) is likely to be due, at least in part, to differences in the transduction efficiencies of the various cell lines. Here, SOX2 is linked to brain neoplasm.